Keynote Speakers

Daniel Chiu, A. Bruce Montgomery Professor of Chemistry Daniel T. Chiu is currently the A. Bruce Montgomery Professor Chemistry, Endowed Professor of Analytical Chemistry, and Professor of Bioengineering at the University of Washington. He is a member of the University of Washington’s Center for Nanotechnology, Neurobiology and Behavior Program, and the Cancer Consortium of the Fred Hutchinson Cancer Research Center. He has authored more than 180 publications and is the inventor on over 40 issued patents. Dr. Chiu obtained a B.A. in neurobiology and a B.S. in chemistry at the University of California, Berkeley in 1993, and a Ph.D. in chemistry from Stanford University in 1998.
Luke Lee, Director Professor Luke P. Lee joined NUS in 2016 as Director of the Biomedical Institute for Global Health Research and Technology (BIGHEART) and appointed as Associate President (International Research and Innovation) in the Office of the Deputy President (Research and Technology). He is also appointed a Tan Chin Tuan Centennial Professor and holds joint appointments in the Departments of Medicine, Surgery, Biomedical Engineering, Chemistry, and Physics. Professor Lee received both his BA and PhD from UC Berkeley. He joined the faculty at UC Berkeley in 1999 after more than a decade of industry experience. He became the Lester John and Lynne Dewar Lloyd Distinguished Professor of Bioengineering in 2005. He also served as the Chair Professor in Systems Nanobiology at the Swiss Federal Institute of Technology (ETH, Zürich) from 2006 to 2007. He became Arnold and Barbara Silverman Distinguished Professor in 2010 and was reappointed again in 2015. His work at the interface of biological, physical, and engineering sciences for medicine has been recognized by many honours that include the IEEE William J. Morlock Award, NSF Career Award, Fulbright Scholar Award, and the HoAm Prize. He is a Fellow of the Royal Society of Chemistry and the American Institute of Medical and Biological Engineering (AIMBE). His current research interests include quantum electron transfers in living organisms, molecular diagnostics of infectious and neurodegenerative diseases, and in vitro neurogenesis, with a focus both on studying fundamental quantum nanobiology and on solving ill-defined problems of global healthcare.